Hungarian Biotech Database

Clinician-scientists from NUHS awarded USD 3.6 million (SGD 4.9 million) grant to further develop the mitral valve bioprosthesis, which mimics the exact appearance, form and physical properties of a human mitral valve Read more ››

By: PR Newswire Association LLC. - 01 Jul 2021

Sanofi: Information concerning the total number of voting rights and shares - May 2021

By: GlobenewsWire - 30 Jun 2021

BioT Raises $6.5 Million in Seed Round to Accelerate the Connected Care Revolution

BioT's SaaS Platform for Digital Health IoT is Set to Transform Healthcare Read more ››

By: PR Newswire Association LLC. - 29 Jun 2021

Sanofi launches dedicated vaccines mRNA Center of Excellence

By: GlobenewsWire - 29 Jun 2021

Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial

By: GlobenewsWire - 28 Jun 2021

Pfizer Highlights Growing Medical and Social Burden of Rheumatoid Arthritis

By: PR Newswire Association LLC. - 28 Jun 2021

IR-Med, Inc. Announces the Appointment of Dr. Rom Eliaz as Chief Executive Officer

By: GlobenewsWire - 25 Jun 2021

Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma

By: GlobenewsWire - 25 Jun 2021

Sanofi: Availability of the Q2 2021 Memorandum for modelling purposes

By: GlobenewsWire - 25 Jun 2021

European Commission approves Aubagio® (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

By: GlobenewsWire - 18 Jun 2021

Roche Expands Partnership With Ghana Ministry of Health to Improve Cancer Care, Opening First of Three New Cancer Centres at Cape Coast Teaching Hospital

Geographic barriers restrict access to cancer treatment; Roche's partnership with the government will work to improve oncology services at hospitals across the country and launch three new cancer treatment centres in 2021. The first cancer treatment centre was launched today at the Cape Coast Teaching... Read more ››

By: PR Newswire Association LLC. - 17 Jun 2021

New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in people with CAD, a serious and chronic autoimmune hemolytic anemia

By: GlobenewsWire - 11 Jun 2021

1 2 3 »

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

August 2021
- Biotechgate Digital Partnering
September 2021
- Swiss Biotech Day 2021
- Digital RESI

See Events »

Add an Event »

Latest company news

Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development
03 Aug 2021 (GlobenewsWire)

Online availability of Sanofi’s half-year financial report for 2021
29 Jul 2021 (GlobenewsWire)

Sales growth accelerated - Full-year guidance raised
29 Jul 2021 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Hungary?

Partners

Upcoming Life Sciences Events

Latest company news